|
Contents of Volume 2 Suppl 1
Second International Symposium on the Molecular Biology of Breast Cancer
Meeting abstracts
Lillehammer, Norway. 12  16 March 2000
|
Meeting abstract
Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene
N Arnold, E Gross, H Peper, K Bandick, W Jonat, M Kiechle
Breast Cancer Res 2000, 2(Suppl 1):P1.01 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up
O Díez, C Pericay, M Domènech, J Brunet, J Cortés, J Balmaña, A Gómez, JJ López, MC Alonso, M Baiget
Breast Cancer Res 2000, 2(Suppl 1):P1.02 (12 March 2000)
[Full text] [PDF]
Meeting abstract
A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course
J Hartikainen, V Kataja, A Mannermaa
Breast Cancer Res 2000, 2(Suppl 1):P1.03 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
SM Johnson, JA Shaw, RA Walker
Breast Cancer Res 2000, 2(Suppl 1):P1.04 (12 March 2000)
[Full text] [PDF]
Meeting abstract
BRCA1 mutation analysis in breast and ovarian cancer families from Greece
I Konstantopoulou, C Croupis, A Ladopoulou, A Pantazidis, E Lianidou, K Venetsanou, E Efstathiou, M Petersen, J Janinis, G Fountzilas, E Chiotellis, D Yannoukakos
Breast Cancer Res 2000, 2(Suppl 1):P1.05 (12 March 2000)
[Full text] [PDF]
Meeting abstract
BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial
Z Kote-Jarai, TP Powles, S Ashley, DF Easton, L Assersohn, N Sodha, M Dowsett, B Gusterson, A Tidy, G Mitchell, RA Eeles
Breast Cancer Res 2000, 2(Suppl 1):P1.06 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
JI Martínez-Ferrandis, A Vega, P Marín-Garcia, F Barros, FJ Chaves, A Carracedo, ME Armengod, I Chirivella, A Lluch, J García-Conde, A Cervantes
Breast Cancer Res 2000, 2(Suppl 1):P1.07 (12 March 2000)
[Full text] [PDF]
Meeting abstract
One test to identify 50% of all Norwegian BRCA1 mutations
P Møller, E Hovig, K Lycke, RAP Stacy, OJ Dahlberg, A Hagen, B Hagen, K Løvslett, H Qvist, K Heimdal
Breast Cancer Res 2000, 2(Suppl 1):P1.08 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline TP53 mutations in Finnish breast cancer patients
K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna, R Winqvist
Breast Cancer Res 2000, 2(Suppl 1):P1.09 (12 March 2000)
[Full text] [PDF]
Meeting abstract
X chromosome inactivation pattern in female patients with breast cancer
M Kristiansen, A Langer, GP Knudsen, BL Weber, A-L Børresen-Dale, KH Ørstavik
Breast Cancer Res 2000, 2(Suppl 1):P1.10 (12 March 2000)
[Full text] [PDF]
Meeting abstract
HRAS1 minisatellite alleles and breast cancer in Spanish women under age forty years
A Vega, JI Martínez, F Barros, P Marín-García, FJ Chavez, C Ruiz-Ponte, I Chirivella, A Lluch, A Cervantes, I García-Conde, ME Armengod, A Carracedo
Breast Cancer Res 2000, 2(Suppl 1):P1.11 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline BRCA2 and somatic P53 alterations in male breast cancer
B Csokay, N Udvarhelyi, E Olah
Breast Cancer Res 2000, 2(Suppl 1):P1.12 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families
M Schwab, L Savelyeva, A Claas, H An, S Brouwers
Breast Cancer Res 2000, 2(Suppl 1):P1.13 (12 March 2000)
[Full text] [PDF]
Meeting abstract
kConFab: a unique Australasian research initiative for familial breast cancer
J Sambrook
Breast Cancer Res 2000, 2(Suppl 1):P1.14 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
C Ghimenti, E Sensi, D Iandolo, G Cipollini, S Ricci, PF Conte, G Bevilacqua, MA Caligo
Breast Cancer Res 2000, 2(Suppl 1):P1.15 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice
NK Collins, KA McAllister, LM Bennett, K-U Wagner, T Ward, J Malphurs, G Goulding, EM Eddy, BJ Davis, RW Wiseman
Breast Cancer Res 2000, 2(Suppl 1):P1.16 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions
P Mote, C Clarke
Breast Cancer Res 2000, 2(Suppl 1):P2.01 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways
BK Lundholt, P Briand, AE Lykkesfeldt
Breast Cancer Res 2000, 2(Suppl 1):P2.02 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines
A Ström, N Arai, J Leers, J-Å Gustafsson
Breast Cancer Res 2000, 2(Suppl 1):P2.03 (12 March 2000)
[Full text] [PDF]
Meeting abstract
Genetic variants of CYP19 (aromatase) and breast cancer risk
V Nedelcheva Kristensen, N Harada, N Yoshimura, E Haraldsen, PE Lønning, B Erikstein, R Kåresen, T Kristensen, A-L Børresen-Dale
Breast Cancer Res 2000, 2(Suppl 1):P2.04 (12 March 2000)
[Full text] [PDF]
|
